Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
about
Tuberculosis therapy for 2016 and beyond.Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.The paradigm shift to end tuberculosis. Are we ready to assume the changes?Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.Linezolid: a review of its properties, function, and use in critical care.
P2860
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
@ast
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
@en
type
label
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
@ast
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
@en
prefLabel
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
@ast
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
@en
P2093
P2860
P356
P1433
P1476
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy.
@en
P2093
Arnold Louie
Ashley N Brown
Awewura Kwara
David L Brown
Dodge L Baluya
George L Drusano
Jaime L Rodriquez
Jonathan R Adams
Kalyani Jambunathan
Richard Hafner
P2860
P304
P356
10.1128/MBIO.01741-15
P577
2015-11-03T00:00:00Z